View Larger Image

Professor Ruth Roberts and Dr Paul Duffy recently spent some time with the Servier nonclinical safety team in Paris, hosted by Dr Nancy Claude, Director of Non-Clinical Safety at Servier and Patrick Genissel, Director Centre of Excellence Research & Biopharmacy, R & D VP.

The discussions focused on science-led strategies to nonclinical development of new molecules, especially complex biologics. Paul presented a number of interesting case studies to illustrate how things can be done differently followed by a round table discussion on projects led by the Servier experts. The day was a great success with many areas identified for future collaboration.

“It was great to catch up with Nancy”, said Ruth. “We have worked together as friends and colleagues for over 15 years and it’s a real pleasure to meet the Servier team”.

By Ruth Roberts|2019-05-28T10:18:11+01:00May 26th, 2019|Toxicology, Events|Comments Off

About the Author: Ruth Roberts

Professor Ruth A Roberts, PhD, ATS, FBTS, ERT, FRSB, FRCPath. A co-founder of ApconiX, Ruth has 25 years of experience in leading roles in drug safety within large pharma. Ruth is also Chair and Director of Drug Discovery at The University of Birmingham, UK and was previously Global Head of Regulatory Safety at AstraZeneca. With over 140 publications in peer-reviewed journals, she is former president of the British Toxicology Society, former president of EUROTOX, former secretary to SOT and President of the Academy of Toxicological Sciences. Ruth was the recipient of the SOT Achievement award in 2002, the EUROTOX Bo Holmstedt Award in 2009 and the SOT Founders award in 2018 for outstanding leadership in toxicology. Ruth is an established science professional bringing rigorous expert thinking to toxicology, drug discovery and drug development.